Markets:

Overview

News

Currencies

International

Treasuries

Vertex Pharmaceuticals (NQ:VRTX)

432.52 +10.20 (+2.42%)

Streaming Delayed Price Updated: 12:44 PM EST, Nov 21, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Vertex Pharmaceuticals

< Previous 1 2

...

15 16 17 18 19 20 21 22 23

...

68 69 Next >

Why VERTEX PHARMACEUTICALS INC (NASDAQ:VRTX) qualifies as a quality stock. ↗

July 25, 2024

Is VERTEX PHARMACEUTICALS INC (NASDAQ:VRTX) suited for quality investing?

Via Chartmill

3 Reasons to Buy Vertex Pharmaceuticals Stock Like There's No Tomorrow ↗

July 25, 2024

Vertex shares have soared by triple-digit percentages over the past three years.

Via The Motley Fool

7 Biotech Stocks to Keep on Your Clinical Radar ↗

July 23, 2024

Biotech stocks have always been relevant. However, with the latest shift in the political race, this sector is bound to grab more eyeballs.

Via InvestorPlace

Here's How Much $100 Invested In Vertex Pharmaceuticals 5 Years Ago Would Be Worth Today ↗

July 23, 2024

Via Benzinga

3 Gene Editing Stocks Shaping the Future of Medicine ↗

July 22, 2024

Gene editing stocks offer a bold venture into biopharma's future, leveraging CRISPR technology for transformative healthcare solutions

Via InvestorPlace

2 Historically Flawless Metrics Suggest the Stock Market Can Plunge: Here Are 3 Stocks I've Sold Ahead of What May Be a Big Move for Wall Street ↗

July 21, 2024

Neither of these predictive indicators has ever been wrong when back-tested for more than 150 years!

Via The Motley Fool

Forecasting The Future: 13 Analyst Projections For Vertex Pharmaceuticals ↗

July 11, 2024

Via Benzinga

Check Out What Whales Are Doing With VRTX ↗

July 10, 2024

Via Benzinga

3 Monster Stocks in the Making to Buy Right Now ↗

July 20, 2024

They're small now, but these stocks could grow much larger.

Via The Motley Fool

The 3 Best Neuroscience Biotech Stocks to Buy Now ↗

July 19, 2024

Given the high bar to developing good neuroscience drugs, firms that do so will likely succeed. Here are three top biotech stocks to buy now.

Via InvestorPlace

Looking for growth without the hefty price tag? Consider NASDAQ:VRTX. ↗

July 19, 2024

VERTEX PHARMACEUTICALS INC (NASDAQ:VRTX) is not too expensive for the growth it is showing.

Via Chartmill

3 Gene Editing Stocks That Could Grow Your Wealth ↗

July 17, 2024

Investors looking for gene editing stocks of cutting edge technology firms should consider these biotech stocks.

Via InvestorPlace

Could CRISPR Therapeutics Become the Next Vertex Pharmaceuticals? ↗

July 16, 2024

CRISPR Therapeutics could start reporting product revenue soon.

Via The Motley Fool

Bull Market and Beyond: 2 Stocks Just Waiting to Soar ↗

July 15, 2024

These innovative drugmakers are hard to ignore.

Via The Motley Fool

Why the quality investor may take a look at NASDAQ:VRTX. ↗

July 03, 2024

Examining the Quality Attributes of NASDAQ:VRTX.

Via Chartmill

Stock-Split Watch: 2 Healthcare Stocks That Look Ready to Split ↗

July 15, 2024

Revenue is climbing at these two drug companies -- and the trend should continue.

Via The Motley Fool

Got $1,000? 2 Incredible Growth Stocks to Buy and Hold Forever ↗

July 14, 2024

These companies have what it takes to stand the test of time in a portfolio.

Via The Motley Fool

The 3 Most Undervalued Gene Editing Stocks to Buy in July 2024 ↗

July 09, 2024

Finding undervalued gene editing stocks is easy, but having the patience to stick with them is the challenge.

Via InvestorPlace

Healthcare Stocks Continue To Lag The Market-Can Anything Help ? ↗

July 08, 2024

Healthcare stocks continue to lag the market up about 6% YTD, helped by Large Cap Biopharma but hurt by United Health.

Via Talk Markets

3 No-Brainer Stocks to Buy in July ↗

July 08, 2024

Investors shouldn't have to think too hard about these great stocks.

Via The Motley Fool

3 Pharma Stocks Already Ushering in the Next Biotech Boom ↗

July 08, 2024

So long as diseases afflict the human condition, there will likely always be a need for pharma stocks. Here are three to consider.

Via InvestorPlace

Prediction: This Will Be Vertex Pharmaceuticals' New Billion-Dollar Growth Driver (and It's Coming Soon). ↗

July 06, 2024

Vertex shares have advanced by triple digits over the past few years.

Via The Motley Fool

The 3 Best Biotech Stocks to Buy in July 2024 ↗

July 05, 2024

For investors looking for promising biotech investments should explore the best biotech stocks to watch in July 2024.

Via InvestorPlace

1 Stock That Increased 10,000% in 33 Years to Buy and Hold Forever ↗

July 05, 2024

It's not too late to get in on the act.

Via The Motley Fool

Did Vertex Pharmaceuticals Just Invent the Next Ozempic? ↗

July 05, 2024

Vertex Pharmaceuticals likely has a breakthrough medicine on its hands.

Via The Motley Fool

Forget Eli Lilly: 3 Biotech Stocks to Buy Instead ↗

July 04, 2024

Eli Lilly is a good stock to buy, but these should be even better.

Via The Motley Fool

3 Top-Rated Gene Editing Stocks Actually Making Money ↗

July 03, 2024

Profitable gene editing stocks make increasingly compelling investments as therapies commercialize this year and beyond.

Via InvestorPlace

Biotech Stock Breakout: IBB Eyes Resistance with Amgen and Vertex

July 02, 2024

The biotech sector (IBB) is trading just 3% away from its 52-week high and a significant resistance level, suggesting a potential breakout.

Via MarketBeat

Topics ETFs

Vertex Announces FDA Acceptance of New Drug Application for Vanzacaftor/Tezacaftor/Deutivacaftor, a Next-In-Class Triple Combination Treatment for Cystic Fibrosis

July 02, 2024

From Vertex Pharmaceuticals Incorporated

Via Business Wire

3 Under-the-Radar Biotech Stocks With Blockbuster Potential ↗

July 02, 2024

Are you looking to boost your portfolio with the best under-the-radar biotech stocks? Here are the top three.

Via InvestorPlace

< Previous 1 2

...

15 16 17 18 19 20 21 22 23

...

68 69 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.